Published in Muscle Nerve on February 01, 1995
The passive mechanical properties of the extensor digitorum longus muscle are compromised in 2- to 20-mo-old mdx mice. J Appl Physiol (1985) (2011) 1.75
Tyrosine-phosphorylated and nonphosphorylated isoforms of alpha-dystrobrevin: roles in skeletal muscle and its neuromuscular and myotendinous junctions. J Cell Biol (2003) 1.15
Molecular and cellular adaptations to chronic myotendinous strain injury in mdx mice expressing a truncated dystrophin. Hum Mol Genet (2008) 0.91
Collagen content does not alter the passive mechanical properties of fibrotic skeletal muscle in mdx mice. Am J Physiol Cell Physiol (2014) 0.86
Growth hormone plus resistance exercise attenuate structural changes in rat myotendinous junctions resulting from chronic unloading. Eur J Histochem (2013) 0.80
Strains at the myotendinous junction predicted by a micromechanical model. J Biomech (2011) 0.79
Oncogenic response of rat skin, lungs, and bones to vinyl chloride. Cancer Res (1971) 4.39
A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol (2001) 3.41
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat Med (1999) 2.27
Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci U S A (1996) 2.06
Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell (2000) 1.98
Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle. Clin Immunol (2001) 1.94
Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J Biol Chem (1995) 1.88
Calpains are activated in necrotic fibers from mdx dystrophic mice. J Biol Chem (1995) 1.74
Differential response of macrophage subpopulations to soleus muscle reloading after rat hindlimb suspension. J Appl Physiol (1985) (1994) 1.67
Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. J Clin Invest (1997) 1.61
Transcellular transactivation by the human immunodeficiency virus type 1 tat protein. J Virol (1991) 1.57
Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett (2000) 1.50
Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro. Hum Mol Genet (2004) 1.48
Do immune cells promote the pathology of dystrophin-deficient myopathies? Neuromuscul Disord (2001) 1.43
Retention magnets in guiding plates of distal-extension removable partial dentures. J Prosthet Dent (1988) 1.37
Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells. Cancer Res (1981) 1.29
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P). Vaccine (2001) 1.26
The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells. Blood (1995) 1.21
Osseointegration enhanced by chemical etching of the titanium surface. A torque removal study in the rabbit. Clin Oral Implants Res (1997) 1.19
Modulation of myostatin expression during modified muscle use. FASEB J (2000) 1.19
Talin at myotendinous junctions. J Cell Biol (1986) 1.16
Intestinal localization of anisakiasis manifested as acute abdomen. Clin Microbiol Infect (2003) 1.13
Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis. J Cell Sci (1994) 1.13
Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells. Proc Natl Acad Sci U S A (1986) 1.12
Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors. Am J Pathol (2000) 1.11
Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin. J Immunol (1999) 1.10
Early endosseous integration enhanced by dual acid etching of titanium: a torque removal study in the rabbit. Clin Oral Implants Res (2001) 1.10
Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP-AON complexes. Gene Ther (2009) 1.08
Complement activation promotes muscle inflammation during modified muscle use. Am J Pathol (2000) 1.07
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli. Mol Cell Biol (1984) 1.06
Desmin integrates the three-dimensional mechanical properties of muscles. Am J Physiol Cell Physiol (2001) 1.04
Familial exudative vitreoretinopathy. Trans Am Ophthalmol Soc (1981) 1.03
Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells. J Natl Cancer Inst (1981) 1.03
Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma. J Virol (2001) 1.02
Glucocorticoids increase the endocytic activity of human dendritic cells. Int Immunol (1999) 1.00
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine. J Med Primatol (2000) 0.99
Alpha-actinin is absent from the terminal segments of myofibrils and from subsarcolemmal densities in frog skeletal muscle. Exp Cell Res (1987) 0.99
Construction and identification by partial nucleotide sequence analysis of bovine casein and beta-lactoglobulin cDNA clones. DNA (1982) 0.99
Nitric oxide inhibits calpain-mediated proteolysis of talin in skeletal muscle cells. Am J Physiol Cell Physiol (2000) 0.98
Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat. J Biol Chem (2001) 0.97
Dystrophin deficiency is associated with myotendinous junction defects in prenecrotic and fully regenerated skeletal muscle. Am J Pathol (1993) 0.97
Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. Br J Haematol (1995) 0.96
Psychological distress and coping strategies in patients with psoriasis: the PSYCHAE Study. J Eur Acad Dermatol Venereol (2007) 0.95
Myotendinous junctions of tonic muscle cells: structure and loading. Cell Tissue Res (1986) 0.94
Episomal DNA of a BK virus variant in a human insulinoma. J Med Virol (1983) 0.93
Myotendinous junction: morphological changes and mechanical failure associated with muscle cell atrophy. Exp Mol Pathol (1984) 0.93
Language and thought disorder in schizophrenia: brain morphological correlates. Schizophr Res (1995) 0.92
In vitro and in vivo potentiation by lonidamine of the antitumor effect of adriamycin. Anticancer Res (1987) 0.92
Find structural aspects of anthozoan desmocyte development (phylum Cnidaria). Tissue Cell (1982) 0.92
DC current pulses for OTSC clip fragmentation: technology and experimental study. Surg Endosc (2014) 0.92
Myotendinous junction injury in relation to junction structure and molecular composition. Exerc Sport Sci Rev (1991) 0.90
Energy stored and dissipated in skeletal muscle basement membranes during sinusoidal oscillations. Biophys J (1986) 0.90
Calpain II expression is increased by changes in mechanical loading of muscle in vivo. J Cell Biochem (1997) 0.89
Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene. Am J Pathol (2000) 0.89
A physical interaction between the cell death protein Fas and the tyrosine kinase p59fynT. J Biol Chem (1996) 0.87
Administration of the non-steroidal anti-inflammatory drug ibuprofen increases macrophage concentrations but reduces necrosis during modified muscle use. Inflamm Res (2003) 0.87
The cytotoxic T cell proteinase granzyme B does not activate interleukin-1 beta-converting enzyme. J Biol Chem (1994) 0.87
HIV-1 Tat mutants in the cysteine-rich region downregulate HLA class II expression in T lymphocytic and macrophage cell lines. Eur J Immunol (2000) 0.86
Nitric oxide synthase inhibitors reduce sarcomere addition in rat skeletal muscle. J Physiol (1999) 0.86
The geometry of actin filament-membrane associations can modify adhesive strength of the myotendinous junction. Cell Motil (1983) 0.86
Macrophage activation and muscle remodeling at myotendinous junctions after modifications in muscle loading. Am J Pathol (1994) 0.86
Nitric oxide synthase inhibition reduces muscle inflammation and necrosis in modified muscle use. J Leukoc Biol (1998) 0.86
Modifications in myotendinous junction surface morphology in dystrophin-deficient mouse muscle. Exp Mol Pathol (1994) 0.86
Evolution of and risk factors for psychological distress in patients with psoriasis: the PSYCHAE study. Int J Immunopathol Pharmacol (2010) 0.86
Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice. Exp Cell Res (1996) 0.85
Calpain concentration is elevated although net calcium-dependent proteolysis is suppressed in dystrophin-deficient muscle. Exp Cell Res (1992) 0.85
Identification of calcium-activated neutral protease activity and regulation by parathyroid hormone in mouse osteoblastic cells. Biochem Mol Biol Int (1993) 0.85
Relative flexural strength of dental restorative ceramics. Dent Mater (1990) 0.85
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant. J Med Virol (1993) 0.84
Importance of experimental data for the improvement of the therapeutical effect of bleomycin. Prog Biochem Pharmacol (1976) 0.84
Sparing of mdx extraocular muscles from dystrophic pathology is not attributable to normalized concentration or distribution of neuronal nitric oxide synthase. Neuromuscul Disord (1998) 0.84
DNA immunization with HIV-1 tat mutated in the trans activation domain induces humoral and cellular immune responses against wild-type Tat. J Immunol (1999) 0.84
Absence of calpain 3 in a form of limb-girdle muscular dystrophy (LGMD2A). J Neurol Sci (1997) 0.84
Occlusal force transfer by removable partial denture designs for a radical maxillectomy. J Prosthet Dent (1985) 0.84
Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTL. Vaccine (2003) 0.84
Myxoma virus Serp2 is a weak inhibitor of granzyme B and interleukin-1beta-converting enzyme in vitro and unlike CrmA cannot block apoptosis in cowpox virus-infected cells. J Virol (1999) 0.83
Elastic energy storage in rigored skeletal muscle cells under physiological loading conditions. Am J Physiol (1986) 0.83
Transformation of human embryonic fibroblasts by BK virus, BK virus DNA and a subgenomic BK virus DNA fragment. J Gen Virol (1982) 0.83
Carcinogenicity studies on vinylidene chloride. Environ Health Perspect (1977) 0.83
Antigens of Yoshida tumour cells. J Pathol (1969) 0.83
An evaluation of primary enamel pretreatments and their effects on resin retention. J Dent Res (1979) 0.82
[Cardiovascular and urological combined operation in a patient with severe aortic stenosis and renal cell carcinoma]. Minerva Urol Nefrol (2008) 0.82
The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells. Oncogene (1999) 0.82
Oncogenity of BK virus for immunosuppressed hamsters. Arch Virol (1982) 0.81
Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice. Am J Pathol (1999) 0.81
Enhancing effect of lonidamine on the inhibition of mitochondrial respiration by adriamycin. Anticancer Res (1987) 0.81
An application of propensity score methods to estimate the treatment effect of corticosteroids in patients with severe cutaneous adverse reactions. Pharmacoepidemiol Drug Saf (2010) 0.80
The effect of the association of Gossypol and Lonidamine on the energy metabolism of Ehrlich ascites tumor cells. Exp Mol Pathol (1983) 0.80
Preliminary results in some tumor systems with indazolecarboxylic acids. Chemotherapy (1981) 0.80
Antibodies to BK virus structural and tumor antigens in human sera from normal persons and from patients with various diseases, including neoplasia. Infect Immun (1976) 0.80
Biomechanics. J Calif Dent Assoc (1988) 0.80
Growth hormone plus resistance exercise attenuate structural changes in rat myotendinous junctions resulting from chronic unloading. Eur J Histochem (2013) 0.80
An alternative to the flat substrate method of preparing electron microscope autoradiographs. Stain Technol (1981) 0.79
Purification of a-amylase from C3H mouse submaxillary gland by gel filtration. J Chromatogr (1970) 0.79
The role of mitochondrial hexokinase in neoplastic phenotype and its sensitivity to lonidamine. Ann N Y Acad Sci (1988) 0.79
Lipoprotein secretion during the formation of the axial skeleton in Leptogorgia virgulata (Cnidaria: Gorgonacea). Cell Tissue Res (1981) 0.79
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B. Biotechniques (1991) 0.79
Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane. Eur J Cancer (2004) 0.79
Two different electrophysiological responses to ryanodine: evidence for two populations of muscles isolated from the rabbit right ventricle. J Mol Cell Cardiol (1987) 0.79